Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

Recruiting now · Not applicable

Conditions studied: Detoxification, Inflammation, Biological Aging

In brief

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Key facts

Study ID

NCT07579845

Run by

OvationLab

People needed

60

Starts

2026-05-05

Expected to finish

2026-09-01

Last updated by the study team

2026-05-29

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult females or males age ≥ 40 years
• Ability to read and speak English

You may not qualify if…

• Current use of a dietary supplement containing fulvic or humic acid
• Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella
• Known allergies to any ingredients in the product
• Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
• Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
• Participants unable to provide consent

Where it is running

• OvationLab — Richmond, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.